Opinion: Proskauer litigators say a growing body of cases show how text messages using emojis are being used to prove intent, ...

Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. Apps are a fundamental part of modern technology. And if ...

Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic kidney disease (ADPKD) for $800 million upfront in a deal that could have a ...